Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20.39M | $61.0M | 10.48% | +7.59M | 2026-06-30 |
| Deep Track Capital, LP | 19.25M | $58.0M | 9.90% | -- | 2026-06-30 |
| State Street Corp | 12.10M | $36.0M | 6.22% | +4.95M | 2026-06-30 |
| TCG Crossover Management, LLC | 10.00M | $30.0M | 5.14% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 8.18M | $24.0M | 4.21% | +2.52M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.33M | $22.0M | 3.77% | +1.95M | 2026-06-30 |
| Marshall Wace, LLP | 6.84M | $20.0M | 3.52% | +2.82M | 2026-06-30 |
| Viking Global Investors LP | 6.70M | $20.0M | 3.45% | -- | 2026-06-30 |
| RA Capital Management, L.P. | 6.50M | $19.0M | 3.34% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 5.01M | $15.0M | 2.58% | +1.90M | 2026-06-30 |
